Engage in the Latest Innovations in Wearable Injectors and Connected Devices! SAE Media Group’s 3rd Annual Wearable Injectors and Connected Devices USA Conference returns to Boston on September 8–9, 2025, bringing together the latest innovations in connected, on-body drug delivery. Designed for professionals in injectable drug delivery and digital health, this two-day event will explore critical advancements in large-volume drug delivery, digital integration, […]

The 4th PAT & Real Time Quality Summit is the leading industry-specific forum for Process Analytical Technology (PAT) professionals in the biotech and pharmaceutical sectors. Taking place at a pivotal time, with the recent release of USP General Chapter <1037> and anticipated FDA guidelines on PAT due in July 2025, this summit is tailored to help organizations […]

Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADC conference calendar. Back for its second year, the ADC Partnering & Investment Summit unites 100+ top ADC companies, pharma leaders, and investors for hyper-aligned and more efficient business networking. Unite with other ADC business development […]

Fuelled by industry excitement like the world-first approval of a digital pathology CDx, the biomarker and diagnostics field continues to surge. Uniting 600+ precision medicine experts this September, the 15th World Clinical Biomarkers & Companion Diagnostics Summit returns with a refreshed 4-day, 3-track, 50+-speaker program, ready to facilitate connection-making and knowledge-sharing to bring affordable precision […]

Showcasing biopharma innovation in 2025, the 7th Exosome-Based Therapeutics Development Summit returns to Boston as the industry’s only dedicated forum covering the full exosome development pipeline, from discovery and optimized characterization to scalable manufacturing and clinical translation. This year’s Summit brings together key players from Direct Biologics, Rion, Aegle Therapeutics, Aruna Bio, EXO Biologics, and […]

With baby KJ successfully receiving the world’s first personalized CRISPR therapy, alongside continued innovation across in vivo and base editing, and rapid ex vivo clinical progress, the genome editing field stands at a pivotal juncture. To mark this definitive CRISPR milestone, the 6th Genome Editing Therapeutics Summit returns to Boston to celebrate ongoing progress, whilst […]

As 2025 shapes up to be a transformative year for talent acquisition in life sciences, the 7th LEAP TA: Life Sciences returns to Boston, MA this September (29 - October 1), uniting over 120 senior TA professionals from industry pioneers including Pfizer, AbbVie, Bristol Myers Squibb, Bayer, Edwards Lifesciences, The Jackson Laboratory, and more. This is […]

The 9th MASH Drug Development Summit is the definitive meeting for pharma and biotech leaders advancing the next generation of therapies for MASH. With the approval of Rezdiffra signaling a new era, the race is on to deliver more effective, patient-centered treatments. This year, dive into novel mechanisms of action, non-invasive biomarkers, and strategic combination […]

Unlock the future of cell and gene therapy manufacturing at the 2nd Raw Materials for Cell & Gene Therapy Summit. This is your exclusive opportunity to hear directly from regulatory and standards leaders such as Andrew Sarafanov (FDA) and Rebecca Potts (USP), as they share the latest thinking on BLA review expectations, raw material characterization, […]

Driving Analytical Excellence from Pre-IND Through BLA for Next-Generation Gene Therapies Returning to Boston this October, the 7th Gene Therapy Analytical Development Summit is the industry’s definitive meeting for advancing assay development and analytical strategy across the gene therapy lifecycle. As gene therapy platforms expand beyond AAV to encompass mRNA, CRISPR-based modalities, LNPs, and novel […]

The 3rd Spatial Biology for Drug Development Summit is your opportunity to come together with leading biopharma experts to address these challenges within the spatial biology space head-on. Across an intensive 2-day agenda, you’ll explore practical solutions to issues spanning data infrastructure, multi-omics integration, standardization, scalability, and translation into the clinic. This year’s forum will […]

With CMS introducing new guidance for RWD studies, the FDA announcing a new RWE Center, and RWD becoming more accessible, it is clear that RWE will play an increasingly pivotal role in the drug development lifecycle. But uncertainties still remain for the experts applying RWE. Returning to Boston, the 13th IMPACCT Real-World Evidence Summit is […]

 Returning as the industry’s definitive forum from early discovery to clinical development, the 8th Annual TPD & Induced Proximity Summit is the world’s largest and longest-standing forum for proximity-based modalities, enabling you to fully immerse yourself in the breadth and depth of cutting-edge induced proximity therapeutic development. Featuring key leaders such as Arvinas, Nurix Therapeutics, C4 Therapeutics, and […]

The rare disease trial landscape stands at a pivotal tipping point. While unprecedented advances in trial design, digital tools, and regulatory flexibility are accelerating innovation like never before, the reality for patients remains stark: over 90% of rare diseases still lack an FDA-approved treatment. For many, clinical trials represent the only path to care, yet […]

Funding pressures, regulatory shifts, global competition, and relentless layoffs are redefining the pre-commercial biopharma landscape. In this climate, agile, transparent, and people-first leadership is critical to keeping teams engaged, culture strong, and organizations moving forward. LEAP HR: Emerging Biopharma is the only meeting built for senior HR leaders in this space. Over three days in […]

Industry’s Flagship Forum Capturing Advancements Across Discovery, Preclinical, Translational, Clinical & Regulatory Development of Innovative Neuropsychiatric Therapeutics Uniting 150+ discovery, preclinical, translational, clinical, and regulatory leaders, the 8th Neuropsychiatric Drug Development Summit returns to provide you with an unrivaled opportunity to stay attuned to the latest progress while tackling industry’s most pressing challenges across a wide spectrum of mental health indications. […]

Have you considered how microneedle drug delivery systems could revolutionise the future of vaccine and drug administration? This November, join SAE Media’s 4th Annual Transdermal and Microneedle Drug Delivery Conference. Engage with leading drug development and delivery experts in a dynamic, expert-led environment. Connect with forward-thinking innovators to explore cutting-edge case studies, breakthrough vaccine and […]

7th Targeted Radiopharmaceuticals Summit Europe 10–12 November 2025 | Amsterdam Translating Novel Radiopharmaceutical Therapies to Transform the Medical Future Now in its seventh year, the Targeted Radiopharmaceuticals Summit Europe returns to Amsterdam to bring together over 200 leaders in radiopharmaceutical therapy development. Designed to establish radiopharmaceuticals as a core pillar of oncology, this event is […]

Now in its seventh year, the TIL Therapies Summit returns as the leading event dedicated to advancing tumor-infiltrating lymphocytes (TIL) therapies. Taking place November 11–13, 2025, in Boston (MA), this summit unites global experts across biopharma, academia, clinical practice, and manufacturing to accelerate the development and commercialization of next-generation TIL treatments. Following the first-ever FDA […]

2025 has seen a wave of positive anti-fibrosis advances. From Agomab’s Phase 2a results in fibrostenosing Crohn’s, Boehringer’s Phase 3 IPF data, Stanford’s TGF-β work in cardiovascular fibrosis, to over $3B in deals from Lilly, GSK, and others, it’s clear the antifibrotic drug development landscape is undergoing a seismic shift. That’s why this year’s Antifibrotic […]

With the release of the draft ICH M15 guidelines and the FDA’s move to phase out animal testing, regulatory change is accelerating, solidifying Model-Informed Drug Development (MIDD) as a critical, non-negotiable tool in the drug development process. The Model-Informed Drug Development Summit is the first and only industry-focused, 3-day strategic meeting dedicated to exploring how MIDD is […]

3rd LNP Characterization & Analytical Development Summit De-Risk Regulatory Submissions Through Smarter LNP Characterization Curated in collaboration with leading analytical scientists and key LNP stakeholders, the 3rd LNP Characterization & Analytical Development Summit returns with new data, fresh insights, and an expanded speaker lineup. As the definitive forum for LNP analytics and characterization, this summit […]

The Only Industry-Dedicated Summit for Advancing Myeloid Cell Therapies in Oncology, Inflammation and Beyond... Uniting leading experts from pharma, biotech, and academia, the 7th Myeloid-Directed Therapies Summit is the definitive event for anyone developing macrophage- and neutrophil-targeted therapies. As the field pushes beyond T-cells, this forum dives into myeloid reprogramming, cell state heterogeneity, and translational […]

The 9th Dermatology Drug Development Summit is the definitive industry-led forum bringing together a driven community of experts pioneering innovative drug discovery and clinical strategies to improve long-term outcomes for patients with immuno-inflammatory disease. With disease heterogeneity and biomarker discovery fueling a new wave of research, and clinical pipelines facing intensifying competition, the need to develop differentiated, […]

Returning for its third year, the Donor Selection & Cell Source Summit is the only industry-dedicated forum focused exclusively on the strategic and scientific challenges of donor selection and cell sourcing for allogeneic therapies. This summit brings together leading minds from biopharma, blood banks, apheresis providers, and cell therapy innovators to address one of the […]

Diving Into the Complement Cascade to Explore Intervention Points, Harnessing Biomarker Strategies to Identify Optimal Patient Populations, & Exploring the Therapeutic Opportunity from Rare Disease to Inflammation to Autoimmune Disease. So far, 2025 has brought significant excitement and progress to the complement-based therapeutic landscape. Leading biopharma companies like Novartis, Annexon Biosciences and Omeros, are making […]

Recognized as the industry’s leading forum for cell therapy analytical, quality control, assay, and CMC professionals, the 7th Cell Therapy Analytical Development Summit, returns to Boston to provide the expertise needed to prepare your teams for clinical and commercial readiness. Hear directly 80+ experts from Takeda, Arsenal Bio, Bayer, Genentech, Adicet Bio, Quell Therapeutics, and […]

RNA-targeting small molecules are rapidly emerging as a powerful therapeutic reality. From modulating splicing to directly binding RNAs, these molecules offer a revolutionary approach to treating previously undruggable diseases across neurodegenerative, cancer and rare disorders. In 2025 alone, the field has seen major collaborations, including Wayfinder Biosciences with Daiichi Sankyo, Ono Pharmaceutical with Reborna Biosciences, […]

The 2nd Innovation in Obesity Therapeutics Summit will return to San Diego this December. Hear from the titans of the pharmaceutical industry, including Novo Nordisk, Eli Lilly and Boehringer Ingelheim, who will share their groundbreaking research and strategies. The pressure is on to develop best-in-class treatments that transform patient lives. Don't miss this pivotal opportunity […]

With major FDA changes already reshaping the regulatory landscape - and global agencies ramping up scrutiny - 2025 is a pivotal year for cell and gene therapy regulatory professionals. With CBER leadership changes, new FDA draft guidance on post-approval CMC, and potency assays facing heightened scrutiny, the environment is rapidly evolving. Global efforts to align […]